• Myelofibrosis

Dr. Palmer has a clinical interest in myeloproliferative neoplasms, as well as bone marrow transplantation. Her interest is in identifying novel, targeted therapies for patients with myeloproliferative neoplasms, such as essential thrombocythemia, polycythemia vera, and myelofibrosis. She strives to offer innovative therapies to patients in all stages of their disease through clinical trials. She also participates in quality of life research, to understand what factors not only contribute to longevity, but also quality of life. When seeing patients, her focus is on providing appropriate education regarding their disease, to help in a shared decision making process. This ensures that patients receive the care most appropriate for them.